Dimensional Fund Advisors
KERX

Dimensional Fund Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Dimensional Fund Advisors’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-90,792
Closed -$1.28M – 3437
2014
Q4 		$1.28M Hold
90,792
– – ﹤0.01% 2952
2014
Q3 		$1.25M Hold
90,792
– – ﹤0.01% 2957
2014
Q2 		$1.4M Hold
90,792
– – ﹤0.01% 2957
2014
Q1 		$1.55M Sell
90,792
-6,800
-7% -$103K ﹤0.01% 2915
2013
Q4 		$1.26M Hold
97,592
– – ﹤0.01% 2976
2013
Q3 		$986K Sell
97,592
-11,764
-11% -$105K ﹤0.01% 3044
2013
Q2 		$817K Buy
+109,356
New +$855K ﹤0.01% 3065

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors's KERX Position: Q1 2015 in Review

Dimensional Fund Advisors sold out of Keryx Biopharmaceuticals Inc (KERX) in Q1 2015, closing a stake of 90,792 shares — an estimated $1.28M sold.

Dimensional Fund Advisors first reported a position in KERX in Q2 2013 and held it in 7 quarters. The position peaked at $1.55M in Q1 2014. 157 funds tracked by Wall St. Rank hold KERX as of Q1 2015.

  • Dimensional Fund Advisors reported no remaining Keryx Biopharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Dimensional Fund Advisors sold 90,792 Keryx Biopharmaceuticals Inc shares in Q1 2015, an estimated $1.28M.
  • Dimensional Fund Advisors first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 7 quarters.
  • Dimensional Fund Advisors's Keryx Biopharmaceuticals Inc position peaked at $1.55M in Q1 2014.
  • 157 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q1 2015.

Based on Dimensional Fund Advisors's 13F filing for Q1 2015, filed 14 May 2015.